Morning Market Losers

Chyron

shares dipped 15.38% to $0.88 at 9:50 am. Chyron's trailing-twelve-month ROE is -11.24%. Telik

dropped 14.43% to $2.55. Telik has been granted orphan drug designation by the US FDA for the treatment of myelodysplastic syndrome. hhgregg

shares lost 10.52% to $7.06. hhgregg expects around 3.6% decline in its FQ3 net sales. Acasti Pharma

fell 10.26% to $2.42. Acasti Pharma's 52-week trading range is $1.21-3.99.